Synacor Prevails in Stockholder Vote

At Annual Meeting, Synacor Stockholders Decisively Vote with Management to:

• Reelect Himesh Bhise, Andrew Kau and Jordan Levy to Board of Directors
• Ratify stockholder rights agreement
• Ratify Deloitte & Touche LLP as independent registered public accounting firm

BUFFALO, N.Y., April 22, 2015 (GLOBE NEWSWIRE) -- Synacor Inc. (Nasdaq: SYNC), the trusted technology development, multiplatform services and revenue partner for video, internet and communications providers, and device manufacturers, today announced the certified results of its Annual Meeting of Stockholders held on April 20, 2015. At the meeting, stockholders elected Himesh Bhise, Andrew Kau and Jordan Levy as Class I members of the Board of Directors to serve until the 2018 annual meeting of stockholders. Stockholders also ratified the Company's stockholder rights agreement and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Synacor's fiscal year ending December 31, 2015.

"The stockholder vote is a definitive endorsement of our strategy, our team, the progress we've made to return the company to profitability, and the opportunity that lies ahead," said Synacor CEO Himesh Bhise. "We're grateful for the confidence from Synacor stockholders, both institutional and individual. With the overhang and distraction of the proxy contest now behind us, we will continue to focus on the work ahead to drive profitable growth and stockholder value."

About Synacor

Synacor (Nasdaq: SYNC) is the trusted technology development, multiplatform services and revenue partner for video, internet and communications providers, and device manufacturers. We deliver modern, multiscreen experiences and advertising to their consumers that require scale, actionable data and sophisticated implementation. www.synacor.com

The Synacor logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=11609

Forward-Looking Statements

This release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of management of Synacor, and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive, technological and/or regulatory factors, and other factors affecting the operation of the respective businesses of Synacor. More detailed information about these factors may be found under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations," in Synacor's annual report on Form 10-K for the year ended December 31, 2014, as amended, which is available on the company's website at investor.synacor.com and on the SEC's website at www.sec.gov. Synacor is under no obligation to, and expressly disclaims any such obligation to, update or alter their respective forward-looking statements, whether as a result of new information, future events, or otherwise.

CONTACT: Investor Contact:
         Denise Garcia, Managing Director
         ICR
         [email protected]
         716-362-3309

         Press Contact:
         Meredith Roth, VP, Corporate Communications
         Synacor
         [email protected]
         716-362-3880

You May Also Be Interested In

• Bio-Path Holdings (BPTH) Announces 375K Share Offering at $3.225/sh
• Biohaven Pharma (BHVN) Prices 5.6M Share Offering at $41/sh
• NRx Pharmaceuticals (NRXP) Announces Proposed Share Offering